A Discrete Choice Experiment analysis to understand Treatment Preferences of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States

被引：0
|
作者：
Faiman, Beth [1 ]
Le, Hoa [2 ]
Laurent, Julie [3 ]
Patel, Saurabh [2 ]
Paner-Straseviciute, Agne [2 ]
Zhang, Xinke [4 ]
Mikhael, Joseph [5 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Johnson & Johnson Innovat Med, Raritan, NJ USA
[3] Caren Part EvidentIQ, Munich, Germany
[4] Janssen Sci Affairs, Baltimore, MD USA
[5] City Hope Natl Med Ctr, Duarte, CA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-400
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [1] Treatment Preferences of Patients with Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, Spain, Italy, and Germany: Results from a Discrete Choice Experiment
    Popat, Rakesh
    Ailawadhi, Sikander
    Kleinman, David
    Perera, Sue
    Gorsh, Boris
    Thomas, Caitlin
    Mulnick, Sarah
    O'Neill, Alicia
    Ross, Melissa
    Paka, Prani
    Hanna, Maya
    Molinari, Alexa
    Naine, Shivaranjani
    Gelhorn, Heather
    BLOOD, 2022, 140 : 7211 - 7213
  • [2] Physician treatment preferences for relapsed/refractory multiple myeloma: a discrete choice experiment
    Batchelder, Laurie
    Philpott, Stephanie
    Divino, Victoria
    Boytsov, Natalie
    Maiese, Eric M.
    Hogea, Cosmina
    Buckingham, Trudy
    Chen, Chi-Chang
    Rodriguez, Ana Maria
    FUTURE ONCOLOGY, 2022, 18 (25) : 2843 - 2856
  • [3] Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment
    Thomas, Caitlin
    Ailawadhi, Sikander
    Popat, Rakesh
    Kleinman, David
    Ross, Melissa M.
    Gorsh, Boris
    Mulnick, Sarah
    O'Neill, Alicia
    Paka, Prani
    Hanna, Maya
    Krucien, Nicolas
    Molinari, Alexa
    Gelhorn, Heather L.
    Perera, Sue
    FRONTIERS IN MEDICINE, 2023, 10
  • [4] A Qualitative Study of Patients' Preferences for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM) in the United States, United Kingdom, France, and Germany
    Thomas, Caitlin
    Gelhorn, Heather
    Mulnick, Sarah
    Popat, Rakesh
    Ailawadhi, Sikander
    Kleinman, David
    McDermott, Eleanor
    Gorsh, Boris
    Perera, Sue
    Eliason, Laurie
    Sapra, Sandhya
    Sansbury, Leah
    O'Neill, Alicia
    Paka, Prani
    Galinsky, Jayne
    Tolley, Julia
    Ross, Melissa
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S428 - S428
  • [5] Treatment preferences among triple-class exposed patients with relapsed/refractory multiple myeloma in the United States (US), United Kingdom (UK), and Germany (DE): a discrete choice experiment
    Rodriguez-Otero, Paula
    Michaels-Igbokwe, Christine
    Collacott, Hannah
    Braverman, Julia
    Marshall, Thomas
    Tinel, Antoine
    Dhanda, Devender
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S209 - S209
  • [6] Selinexor for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Anum, Babar
    Hina, Zubair
    Mainoma, Bano
    Sana, Rafique
    Arzu, Shahid
    Maham, Babar
    Waleed, Madeeha S.
    Arslan, Inayat
    Danish, Safi
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S29 - S29
  • [7] PATIENT PREFERENCES REGARDING TREATMENT OPTIONS FOR RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM)
    Bauer, S.
    Mueller, S.
    Ratsch, B.
    Pitura, S.
    Probst, L.
    van Eickels, D.
    Wilke, T.
    VALUE IN HEALTH, 2017, 20 (09) : A451 - A451
  • [8] Patient Preferences for Treatment in Relapsed/ Refractory Acute Leukemia in the United Kingdom: A Discrete Choice Experiment
    Mott, David John
    Hitch, Jake
    Nier, Samantha
    Pemberton-Whiteley, Zack
    Skedgel, Chris
    PATIENT PREFERENCE AND ADHERENCE, 2024, 18 : 1243 - 1255
  • [9] BUDGET IMPACT OF ELRANATAMAB-BCMM IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) IN THE UNITED STATES
    Shah, B.
    Sandin, R.
    Liu, Y.
    Hu, Y.
    Schepart, A.
    Hughes, D.
    Hart, J.
    Hlavacek, P.
    VALUE IN HEALTH, 2024, 27 (06) : S136 - S136
  • [10] Treatment patterns among patients with relapsed/refractory multiple myeloma (RRMM) in Taiwan
    Huang, Jeffrey Shang-Yi
    Wang, Ming-Chung
    Yeh, Su-Peng
    Chen, Tsai-Yun
    Teng, Chieh-Lin Jerry
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S188 - S189
12345